Annual Operating Expenses
$32.05 M
-$9.01 M-21.94%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual total operating expenses is $32.05 million, with the most recent change of -$9.01 million (-21.94%) on December 31, 2023.
- During the last 3 years, PLX annual operating expenses has fallen by -$17.26 million (-35.01%).
- PLX annual operating expenses is now -41.21% below its all-time high of $54.52 million, reached on December 31, 2019.
Performance
PLX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$5.59 M
-$852.00 K-13.22%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly total operating expenses is $5.59 million, with the most recent change of -$852.00 thousand (-13.22%) on September 30, 2024.
- Over the past year, PLX quarterly operating expenses has dropped by -$1.75 million (-23.79%).
- PLX quarterly operating expenses is now -64.19% below its all-time high of $15.62 million, reached on December 31, 2007.
Performance
PLX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PLX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.9% | -23.8% |
| 3 y3 years | -35.0% | -23.8% |
| 5 y5 years | -27.6% | -23.8% |
PLX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.5% | at low | -53.1% | at low |
| 5 y | 5-year | -41.2% | at low | -59.8% | at low |
| alltime | all time | -41.2% | >+9999.0% | -64.2% | >+9999.0% |
Protalix BioTherapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.59 M(-13.2%) |
| Jun 2024 | - | $6.45 M(+7.4%) |
| Mar 2024 | - | $6.00 M(-17.2%) |
| Dec 2023 | $32.05 M(-21.9%) | $7.25 M(-1.3%) |
| Sep 2023 | - | $7.34 M(-13.7%) |
| Jun 2023 | - | $8.51 M(-5.1%) |
| Mar 2023 | - | $8.96 M(+2.8%) |
| Dec 2022 | $41.06 M(-3.3%) | $8.71 M(-14.8%) |
| Sep 2022 | - | $10.23 M(+0.4%) |
| Jun 2022 | - | $10.19 M(-14.5%) |
| Mar 2022 | - | $11.92 M(+7.3%) |
| Dec 2021 | $42.46 M(-13.9%) | $11.11 M(+8.5%) |
| Sep 2021 | - | $10.24 M(-5.7%) |
| Jun 2021 | - | $10.86 M(+5.8%) |
| Mar 2021 | - | $10.26 M(-26.2%) |
| Dec 2020 | $49.31 M(-9.5%) | $13.90 M(+32.4%) |
| Sep 2020 | - | $10.50 M(-7.7%) |
| Jun 2020 | - | $11.38 M(-15.9%) |
| Mar 2020 | - | $13.53 M(+7.3%) |
| Dec 2019 | $54.52 M(+23.2%) | $12.61 M(+0.2%) |
| Sep 2019 | - | $12.59 M(-18.2%) |
| Jun 2019 | - | $15.39 M(+10.5%) |
| Mar 2019 | - | $13.93 M(+18.6%) |
| Dec 2018 | $44.25 M(+9.6%) | $11.75 M(-17.0%) |
| Sep 2018 | - | $14.16 M(+50.6%) |
| Jun 2018 | - | $9.40 M(+5.1%) |
| Mar 2018 | - | $8.94 M(-27.5%) |
| Dec 2017 | $40.36 M(+18.8%) | $12.33 M(+33.7%) |
| Sep 2017 | - | $9.22 M(-20.7%) |
| Jun 2017 | - | $11.64 M(+62.4%) |
| Mar 2017 | - | $7.17 M(-19.0%) |
| Dec 2016 | $33.96 M(+24.4%) | $8.85 M(+25.2%) |
| Sep 2016 | - | $7.07 M(-29.5%) |
| Jun 2016 | - | $10.03 M(+25.0%) |
| Mar 2016 | - | $8.02 M(+4.2%) |
| Dec 2015 | $27.30 M(-13.2%) | $7.70 M(+25.9%) |
| Sep 2015 | - | $6.12 M(-8.7%) |
| Jun 2015 | - | $6.70 M(-1.5%) |
| Mar 2015 | - | $6.79 M(-3.3%) |
| Dec 2014 | $31.45 M(-7.7%) | $7.03 M(-13.4%) |
| Sep 2014 | - | $8.12 M(+24.3%) |
| Jun 2014 | - | $6.53 M(-33.2%) |
| Mar 2014 | - | $9.78 M(-7.6%) |
| Dec 2013 | $34.06 M(-11.4%) | $10.58 M(+42.6%) |
| Sep 2013 | - | $7.42 M(-14.2%) |
| Jun 2013 | - | $8.64 M(+16.3%) |
| Mar 2013 | - | $7.43 M(-17.8%) |
| Dec 2012 | $38.45 M(+1.3%) | $9.04 M(+5.3%) |
| Sep 2012 | - | $8.58 M(-30.6%) |
| Jun 2012 | - | $12.36 M(+45.9%) |
| Mar 2012 | - | $8.47 M(-7.4%) |
| Dec 2011 | $37.97 M | $9.15 M(-3.1%) |
| Sep 2011 | - | $9.44 M(+3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | - | $9.12 M(-11.1%) |
| Mar 2011 | - | $10.26 M(-15.4%) |
| Dec 2010 | $36.83 M(+28.0%) | $12.13 M(+144.2%) |
| Sep 2010 | - | $4.97 M(-53.9%) |
| Jun 2010 | - | $10.76 M(+20.0%) |
| Mar 2010 | - | $8.97 M(-24.2%) |
| Dec 2009 | $28.78 M(+19.1%) | $11.83 M(+95.6%) |
| Sep 2009 | - | $6.05 M(+2.9%) |
| Jun 2009 | - | $5.87 M(+16.6%) |
| Mar 2009 | - | $5.04 M(-20.0%) |
| Dec 2008 | $24.17 M(-29.3%) | $6.29 M(-6.3%) |
| Sep 2008 | - | $6.72 M(+37.2%) |
| Jun 2008 | - | $4.90 M(-21.8%) |
| Mar 2008 | - | $6.26 M(-59.9%) |
| Dec 2007 | $34.16 M(+249.6%) | $15.62 M(+142.8%) |
| Sep 2007 | - | $6.43 M(-31.1%) |
| Jun 2007 | - | $9.34 M(+146.9%) |
| Mar 2007 | - | $3.78 M(+1.2%) |
| Dec 2006 | $9.77 M(+65.5%) | $3.73 M(+47.2%) |
| Sep 2006 | - | $2.54 M(-27.5%) |
| Jun 2006 | - | $3.50 M(+113.7%) |
| Mar 2006 | - | $1.64 M(-72.0%) |
| Dec 2005 | $5.90 M(+116.5%) | $5.84 M(>+9900.0%) |
| Sep 2005 | - | $35.90 K(+76.0%) |
| Jun 2005 | - | $20.40 K(+87.2%) |
| Mar 2005 | - | $10.90 K(-99.6%) |
| Dec 2004 | $2.73 M(+1750.1%) | $2.59 M(+5807.7%) |
| Sep 2004 | - | $43.90 K(-26.7%) |
| Jun 2004 | - | $59.90 K(+101.7%) |
| Mar 2004 | - | $29.70 K(-39.3%) |
| Dec 2003 | $147.40 K(-11.1%) | $48.90 K(+48.2%) |
| Sep 2003 | - | $33.00 K(+6.5%) |
| Jun 2003 | - | $31.00 K(-10.4%) |
| Mar 2003 | - | $34.60 K(-34.1%) |
| Dec 2002 | $165.80 K(-57.0%) | $52.50 K(+46.6%) |
| Sep 2002 | - | $35.80 K(-3.0%) |
| Jun 2002 | - | $36.90 K(-9.1%) |
| Mar 2002 | - | $40.60 K(-74.0%) |
| Dec 2001 | $385.80 K(+1.0%) | $156.20 K(+166.1%) |
| Sep 2001 | - | $58.70 K(-9.7%) |
| Jun 2001 | - | $65.00 K(-38.6%) |
| Mar 2001 | - | $105.80 K(-52.0%) |
| Dec 2000 | $381.90 K(-77.4%) | $220.30 K(+1312.2%) |
| Sep 2000 | - | $15.60 K(-79.9%) |
| Jun 2000 | - | $77.80 K(+14.1%) |
| Mar 2000 | - | $68.20 K(-57.6%) |
| Dec 1999 | $1.69 M(-41.9%) | $161.00 K(-63.2%) |
| Sep 1999 | - | $437.80 K(-5.7%) |
| Jun 1999 | - | $464.10 K(-25.7%) |
| Mar 1999 | - | $624.50 K |
| Dec 1998 | $2.90 M(+1666.6%) | - |
| Dec 1997 | $164.40 K(+272.8%) | - |
| Dec 1996 | $44.10 K | - |
FAQ
- What is Protalix BioTherapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual operating expenses year-on-year change?
- What is Protalix BioTherapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly operating expenses year-on-year change?
What is Protalix BioTherapeutics annual total operating expenses?
The current annual operating expenses of PLX is $32.05 M
What is the all time high annual operating expenses for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual total operating expenses is $54.52 M
What is Protalix BioTherapeutics annual operating expenses year-on-year change?
Over the past year, PLX annual total operating expenses has changed by -$9.01 M (-21.94%)
What is Protalix BioTherapeutics quarterly total operating expenses?
The current quarterly operating expenses of PLX is $5.59 M
What is the all time high quarterly operating expenses for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly total operating expenses is $15.62 M
What is Protalix BioTherapeutics quarterly operating expenses year-on-year change?
Over the past year, PLX quarterly total operating expenses has changed by -$1.75 M (-23.79%)